229 related articles for article (PubMed ID: 18334097)
1. Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration.
Esteban-Fernández D; Verdaguer JM; Ramírez-Camacho R; Palacios MA; Gómez-Gómez MM
J Anal Toxicol; 2008 Mar; 32(2):140-6. PubMed ID: 18334097
[TBL] [Abstract][Full Text] [Related]
2. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents.
Gersten BK; Fitzgerald TS; Fernandez KA; Cunningham LL
J Assoc Res Otolaryngol; 2020 Aug; 21(4):303-321. PubMed ID: 32583132
[TBL] [Abstract][Full Text] [Related]
3. Printing metal-spiked inks for LA-ICP-MS bioimaging internal standardization: comparison of the different nephrotoxic behavior of cisplatin, carboplatin, and oxaliplatin.
Moraleja I; Esteban-Fernández D; Lázaro A; Humanes B; Neumann B; Tejedor A; Luz Mena M; Jakubowski N; Gómez-Gómez MM
Anal Bioanal Chem; 2016 Mar; 408(9):2309-18. PubMed ID: 26825342
[TBL] [Abstract][Full Text] [Related]
4. TCEP-based rSDS-PAGE AND nLC-ESI-LTQ-MS/MS for oxaliplatin metalloproteomic analysis.
Mena ML; Moreno-Gordaliza E; Gómez-Gómez MM
Talanta; 2013 Nov; 116():581-92. PubMed ID: 24148449
[TBL] [Abstract][Full Text] [Related]
5. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
[TBL] [Abstract][Full Text] [Related]
6. Presence of cancerostatic platinum compounds in hospital wastewater and possible elimination by adsorption to activated sludge.
Lenz K; Hann S; Koellensperger G; Stefanka Z; Stingeder G; Weissenbacher N; Mahnik SN; Fuerhacker M
Sci Total Environ; 2005 Jun; 345(1-3):141-52. PubMed ID: 15919535
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic properties of platinium derivatives].
Boisdron-Celle M; Lebouil A; Allain P; Gamelin E
Bull Cancer; 2001 Aug; 88 Spec No():S14-9. PubMed ID: 11567909
[TBL] [Abstract][Full Text] [Related]
8. Interaction of platinum agents, cisplatin, carboplatin and oxaliplatin against albumin in vivo rats and in vitro study using inductively coupled plasma-mass spectrometory.
Kato R; Sato T; Iwamoto A; Yamazaki T; Nakashiro S; Yoshikai S; Fujimoto A; Imano H; Ijiri Y; Mino Y; Chikuma M; Tanaka K; Hayashi T
Biopharm Drug Dispos; 2019 Jul; 40(7):242-249. PubMed ID: 31219617
[TBL] [Abstract][Full Text] [Related]
9. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
10. Tissue platinum after clinical treatment with cisplatin or carboplatin in tumor-bearing patients.
Minami T; Tohno Y; Tohno S; Utsumi M; Yamada M; Hashii K; Tateyama I; Kadota E; Okazaki Y
Biol Trace Elem Res; 1997; 58(1-2):77-83. PubMed ID: 9363322
[TBL] [Abstract][Full Text] [Related]
11. The interaction of platinum-based drugs with native biologically relevant proteins.
Brauckmann C; Wehe CA; Kieshauer M; Lanvers-Kaminsky C; Sperling M; Karst U
Anal Bioanal Chem; 2013 Feb; 405(6):1855-64. PubMed ID: 23052861
[TBL] [Abstract][Full Text] [Related]
12. Distribution study of cisplatin in rat kidney and liver cancer tissues by using liquid chromatography electrospray ionization tandem mass spectrometry.
Bandu R; Ahn HS; Lee JW; Kim YW; Choi SH; Kim HJ; Kim KP
J Mass Spectrom; 2015 Jun; 50(6):844-53. PubMed ID: 26169139
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(IV)-based anticancer agents.
Theiner S; Kornauth C; Varbanov HP; Galanski M; Van Schoonhoven S; Heffeter P; Berger W; Egger AE; Keppler BK
Metallomics; 2015 Aug; 7(8):1256-64. PubMed ID: 25856224
[TBL] [Abstract][Full Text] [Related]
14. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
Jacobs SS; Fox E; Dennie C; Morgan LB; McCully CL; Balis FM
Clin Cancer Res; 2005 Feb; 11(4):1669-74. PubMed ID: 15746072
[TBL] [Abstract][Full Text] [Related]
15. Quality control of pharmaceutical formulations containing cisplatin, carboplatin, and oxaliplatin by micellar and microemulsion electrokinetic chromatography (MEKC, MEEKC).
Nussbaumer S; Fleury-Souverain S; Schappler J; Rudaz S; Veuthey JL; Bonnabry P
J Pharm Biomed Anal; 2011 May; 55(2):253-8. PubMed ID: 21330090
[TBL] [Abstract][Full Text] [Related]
16. Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates.
Jacobs S; McCully CL; Murphy RF; Bacher J; Balis FM; Fox E
Cancer Chemother Pharmacol; 2010 Apr; 65(5):817-24. PubMed ID: 19662415
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin: pharmacokinetics and chronopharmacological aspects.
Lévi F; Metzger G; Massari C; Milano G
Clin Pharmacokinet; 2000 Jan; 38(1):1-21. PubMed ID: 10668856
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-induced hearing loss does not correlate with intracellular platinum concentration.
Ramírez-Camacho R; Fernández DE; Verdaguer JM; Gómez MM; Trinidad A; García-Berrocal JR; Corvillo MA
Acta Otolaryngol; 2008 May; 128(5):505-9. PubMed ID: 18421602
[TBL] [Abstract][Full Text] [Related]
19. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
[TBL] [Abstract][Full Text] [Related]
20. Transport of platinum-based pharmaceuticals in water-saturated sand and natural soil: Carboplatin and cisplatin species.
Goykhman N; Dror I; Berkowitz B
Chemosphere; 2019 Mar; 219():390-399. PubMed ID: 30551105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]